VascVersa

Seed
vascversa.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Aug 8, 2022
Investors Undisclosed
Decision Makers 3 Available

About VascVersa

Pioneering a bold new generation of advanced therapies that decipher the code behind vision loss - helping to restore sight through retinal vascular therapy

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website vascversa.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for VascVersa.

Funding History

1 Round
Seed equity · Aug 8, 2022

Founders & Leadership

3

Christina O'Neill

Co-founder, CEO

Work email & phone locked Unlock →

Professor Alan Stitt

Co-founder

Work email & phone locked Unlock →

Reinhold Medina

Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts